Sharma Mani 的 Form 4 申報
AstraZeneca PLC（AZN），2026/9/11 申報
- 申報編號
- 0001104659-26-107055
- 申報時間
- 2026/9/11 16:05 ET
- 交易日
- 2026/8/8-9/8
- 申報延遲
- 34 天遲報
- 10b5-1 計畫
- 沒有勾選
這份申報列了 2 筆非衍生性交易。公開市場買進合計 $3,248.81。交易後 34 天才申報，超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Sharma ManiCIK 0002122411 | 高階主管（見申報備註） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Represents the automatic reinvestment of dividends accrued during the holding period of the Issuer's Restricted Share Plan, at a price of GBP118.96, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3498 on August 7, 2026 as published by the Board of Governors of the Federal Reserve System. The dividend equivalent units will vest and be released to the Officer at the end of the three year holding period.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Represents the acquisition of shares pursuant to the Issuer's Share Incentive Plan at a price of GBP120.26, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3521 on September 4, 2026 as published by the Board of Governors of the Federal Reserve System.
表 I 有 1 筆交易的價格引用這則附註。
備註
SVP, Group Controller and Head of Global Finance Services